Charcot-Marie-Tooth Disease Axonal Type 2H (CMT2H)

Charcot-Marie-Tooth disease axonal type 2H (CMT2H) is a very rare inherited nerve disease. It mainly damages the long “wiring” parts of the nerves (axons) that carry signals between the spinal cord and the muscles and skin. This causes weakness in the feet and legs, trouble walking, high-arched feet, and later weakness in the hands. CMT2H is an axonal type of Charcot-Marie-Tooth disease with both motor (movement) and sensory (feeling) problems and often some “pyramidal” signs such as increased reflexes or stiffness. It is linked to a region on chromosome 8q13-q23 and is usually inherited in a recessive way, meaning both copies of the gene must carry a change. MalaCards+1

Charcot-Marie-Tooth disease axonal type 2H (CMT2H) is a very rare inherited nerve disease that mainly damages the long nerves in the arms and legs (peripheral nerves). It is an “axonal” neuropathy, which means the central wire of the nerve fiber (the axon) is mostly affected, rather than the myelin coating. This damage causes weakness and wasting of muscles in the feet and hands, loss of feeling, and problems with walking.Rare Diseases Information Center+1

CMT2H is also linked with “pyramidal” signs. Pyramidal signs come from mild damage to the long nerve tracts in the brain and spinal cord that control movement (the corticospinal tracts). Because of this, some reflexes (like the knee reflex) can become overactive, and the legs or arms may feel stiff. This mix of peripheral nerve damage plus pyramidal signs is typical for CMT2H and helps doctors tell it apart from other types of Charcot-Marie-Tooth disease.Rare Diseases Information Center+2MalaCards+2

There is no medicine today that can cure CMT2H or stop it completely. Treatment focuses on three big goals: keeping muscles as strong and flexible as possible, protecting joints and feet from deformity and injury, and controlling pain and fatigue so daily life stays as active and independent as possible. A good plan usually includes neurologists, physiotherapists, occupational therapists, orthopedic surgeons, and sometimes psychologists and dietitians working together over many years. Mayo Clinic+1

CMT2H is genetic and follows an autosomal recessive pattern. This means a person usually develops the disease only if they receive a faulty copy of the same gene from both parents. The condition usually begins in childhood and slowly gets worse over many years. Even though it is progressive and long-lasting, many people live into adulthood, and treatment focuses on managing symptoms and keeping as much function and independence as possible.Rare Diseases Information Center+2Monarch Initiative+2

---

Other names

Doctors and researchers use several other names for CMT2H. Knowing these names is useful when you search for information or medical papers, because different articles may use different terms for the same disease.Rare Diseases Information Center+1

Some other names include:Rare Diseases Information Center+1

• AR-CMT2C (autosomal recessive Charcot-Marie-Tooth type 2C)

• Autosomal recessive axonal Charcot-Marie-Tooth disease with pyramidal features

• Autosomal recessive axonal Charcot-Marie-Tooth neuropathy with pyramidal features

• Autosomal recessive axonal CMT4C2

• Axonal Charcot-Marie-Tooth disease with pyramidal involvement

• Charcot-Marie-Tooth disease type 2H (CMT2H)

All these names point to the same basic problem: a rare, inherited axonal sensorimotor neuropathy with extra signs coming from the pyramidal (corticospinal) system.Rare Diseases Information Center+1

---

Types

CMT2H is one specific subtype inside the large family of Charcot-Marie-Tooth diseases. Doctors do not yet divide CMT2H into many official gene-based subtypes, but they often talk about “types” in a practical clinical way. These clinical types are based on age of onset, severity, and speed of progression, not on different genes.NCBI+1

1. Type by age of onset (childhood vs. later childhood/adolescence)
   Many children with CMT2H show problems with running, tripping, or abnormal walking between about 2 and 11 years. Some may not be recognized until the teenage years if symptoms are mild at first. Doctors sometimes describe “early-childhood onset” versus “later-childhood or adolescent onset” to show when signs first appeared.Rare Diseases Information Center+1

2. Type by severity (mild, moderate, severe)
   Some people have only mild weakness and foot deformity and can walk independently for many years, while others develop stronger weakness, marked foot drop, and may later need walking aids. Calling the disease mild, moderate, or severe helps doctors and families talk about daily function and long-term planning, even though the underlying genetic cause is the same.Muscular Dystrophy Association+1

3. Type by progression speed (slow vs. faster progressive)
   CMT2H is usually slowly progressive, but a few people may notice faster decline in walking ability, especially if pyramidal signs become more obvious. Clinicians sometimes describe “slowly progressive” versus “more rapidly progressive” patterns to help choose therapy intensity and follow-up frequency.NCBI+1

---

Causes

Before listing causes, it is important to say clearly: the main cause of CMT2H is a genetic mutation (pathogenic variant) in a gene located on part of chromosome 8 (region 8q13-q23). Researchers know the location and recessive inheritance pattern, but the exact gene is still being clarified. All other “causes” below describe how this genetic change affects the body or what factors can influence how severe the disease becomes.MalaCards+2orpha.net+2

1. Autosomal recessive genetic mutation
   CMT2H happens when a person inherits two faulty copies of the same gene, one from each parent. Neither parent usually has symptoms because they each have only one mutated copy, but together both copies in the child are damaged and cannot support normal nerve function. This autosomal recessive pattern is confirmed in rare disease databases for CMT2H.Rare Diseases Information Center+1

2. Defective protein needed for long nerve fibers (axons)
   The mutated gene leads to production of an abnormal or missing protein that is important for the health of long axons in motor and sensory nerves. When this protein does not work correctly, the axon slowly degenerates, especially in the longest nerves to the feet and hands, causing progressive weakness and numbness.NCBI+1

3. Damage to motor axons that control muscles
   Motor axons carry signals from the spinal cord to muscles. In CMT2H, these motor axons are damaged first in the lower legs and feet. Over time, the signal from the brain becomes weaker, so the muscles do not contract properly, leading to foot drop, thin lower legs, and difficulty running or climbing stairs.Rare Diseases Information Center+1

4. Damage to sensory axons that carry feeling
   Sensory axons carry information about touch, pain, and position back to the spinal cord and brain. When these axons are injured in CMT2H, people lose feeling in their feet and sometimes hands. This makes it hard to feel the ground, which adds to balance problems and the risk of falls.Rare Diseases Information Center+2Physiopedia+2

5. Length-dependent vulnerability of nerves
   The nerves that travel the farthest from the spinal cord are affected first because they have longer axons that are harder to maintain. That is why symptoms usually start in the feet and lower legs and only later reach the hands. This “length-dependent” pattern is common in axonal forms of Charcot-Marie-Tooth disease.Wikipedia+1

6. Secondary loss of myelinated fibers
   Even though CMT2H is mainly an axonal neuropathy, nerve biopsies in similar axonal CMT conditions show a decreased number of myelinated fibers as damaged axons die back. The loss of both axons and their myelin covering further slows nerve signals and adds to weakness and numbness.Rare Diseases Information Center+1

7. Pyramidal tract involvement in the brain and spinal cord
   In CMT2H, parts of the corticospinal (pyramidal) tract can also be affected. These tracts help control fine, voluntary movements. Mild damage here leads to overactive reflexes and leg stiffness, which combine with peripheral weakness to make walking and balance harder.Rare Diseases Information Center+2Monarch Initiative+2

8. Disrupted axonal transport
   Axons need a strong internal transport system to move nutrients, energy packets (mitochondria), and repair materials from the nerve cell body to the distant ends. In axonal forms of CMT, including those related to genes like MFN2 and GDAP1, this transport system is often disturbed, and similar mechanisms are suspected in CMT2H. This makes distal parts of the nerve more likely to degenerate.Springer Link+1

9. Mitochondrial stress in peripheral nerves
   Many axonal CMT genes affect mitochondria, the “power plants” of the cell. When mitochondrial function is disturbed, nerves cannot make enough energy to keep long axons healthy. Although the exact gene for CMT2H is still being clarified, researchers think similar mitochondrial problems may play a role, based on experience with other axonal CMT subtypes.Nature+1

10. Disturbed interaction between Schwann cells and axons
    Schwann cells support and insulate peripheral axons. Even in axonal forms of CMT, mutations can disturb the communication between Schwann cells and axons. This disturbed interaction may contribute to both axonal loss and secondary myelin changes, worsening the neuropathy over time.Wikipedia+1

11. Genetic background and modifiers
    People with the same main mutation can still have different symptom severity. This suggests that other genes in a person’s genetic background can modify how strongly the disease appears. Such modifier genes are described in CMT in general and likely influence CMT2H as well, although they are not fully known.Springer Link+1

12. Family carriers and consanguinity
    Because CMT2H is autosomal recessive, the disease is more likely when both parents are carriers, especially in families where relatives have children together (consanguinity). In such families, there is a higher chance that a child receives the same mutated gene from both sides.Rare Diseases Information Center+1

13. De novo (new) mutations
    In some rare situations, the disease-causing mutation may appear for the first time in a child (a de novo change), even if there is no family history. This is less common in recessive diseases but still possible, and it explains why some children have CMT2H without known affected relatives.Wikipedia+1

14. Accumulated nerve damage with age
    As a person with CMT2H gets older, the axons have been under stress for many years. This long-term stress can lead to more nerve fiber loss, so weakness and sensory loss gradually worsen over time, even though the gene change has been present since birth.NCBI+1

15. Mechanical stress on already weak feet and ankles
    Foot deformities such as pes cavus and ankle instability place uneven forces on bones and joints. This mechanical stress can further strain already weak muscles and damaged nerves, so walking becomes harder and pain may increase. This does not cause the disease, but it adds to the problems it creates.Muscular Dystrophy Association+1

16. Reduced regenerative capacity of nerves
    In CMT2H, the ability of peripheral nerves to regenerate after injury is reduced. Human Phenotype Ontology data note “axonal regeneration” changes in this condition, which reflect abnormal repair attempts in damaged nerve fibers. These incomplete repairs help explain why recovery from nerve strain or minor injury is poor.Rare Diseases Information Center+1

17. Chronic denervation of muscles
    Because nerve supply to muscles is slowly lost, muscle fibers become denervated and shrink. The body sometimes tries to re-innervate them through neighboring motor units, but this is often not enough. Over years, this chronic denervation leads to visible muscle wasting in the feet, legs, and later the hands.Rare Diseases Information Center+1

18. Impaired proprioception (sense of position)
    Sensory nerve damage in CMT2H affects proprioceptive fibers that tell the brain where the joints and limbs are in space. When this system fails, the brain cannot finely control leg position during walking, which increases tripping and unsteady gait. This functional loss is a direct result of the underlying axonal neuropathy.Physiopedia+1

19. Possible overlap with other CMT genes in some families
    Some families with axonal CMT show changes in genes like GDAP1 or MFN2, while mapping studies also link disease to chromosome 8q regions. This suggests that in some lineages, CMT2H-like pictures might involve more than one gene, although this is still being researched.Nature+2Springer Link+2

20. Unknown environmental and biological modifiers
    As with many genetic diseases, there may be environmental factors (such as general health, activity level, or repeated ankle injuries) and other biological factors (like hormone changes) that change when symptoms start or how fast they progress. These do not cause CMT2H by themselves but can modify the course of the disease in each person.Rare Diseases Information Center+1

---

Symptoms

1. Distal muscle weakness in feet and lower legs
   One of the most common early symptoms is weakness in the muscles that move the feet and toes. Children may struggle to lift their toes up or push off strongly when running. This distal weakness happens because the long motor nerves to these muscles are damaged and cannot carry full signals.Rare Diseases Information Center+2Muscular Dystrophy Association+2

2. Distal muscle wasting (thinning of lower legs and feet)
   Over time, the weak muscles become smaller and thinner, especially below the knees. Doctors sometimes describe the lower legs as looking like an “inverted champagne bottle,” with thin calves and relatively normal thighs. This wasting shows long-standing nerve damage and loss of muscle fibers.Rare Diseases Information Center+2Mayo Clinic+2

3. Foot drop (foot dorsiflexor weakness)
   Foot drop means the person has trouble lifting the front part of the foot while walking. In CMT2H, weakness of the muscles that pull the foot upward causes the toes to drag, leading to frequent tripping unless the person compensates with a high-stepping gait.Rare Diseases Information Center+2Mayo Clinic+2

4. Steppage gait (high-stepping walk)
   To avoid dragging the toes, many people with CMT2H lift their knees higher when they walk, creating a “steppage” or high-stepping gait. This unusual walking style is a classic sign of CMT and reflects the combination of foot drop, muscle weakness, and poor ankle control.Rare Diseases Information Center+2Wikipedia+2

5. High-arched feet (pes cavus)
   Pes cavus means abnormally high arches of the feet. In CMT2H, muscle imbalance around the foot and ankle slowly pulls the foot into this shape. High arches can make shoe fitting difficult and increase pressure on certain parts of the foot, contributing to pain and calluses.Rare Diseases Information Center+2Muscular Dystrophy Association+2

6. Absent Achilles reflex
   The Achilles reflex is tested by gently tapping the tendon at the back of the ankle. In CMT2H, this reflex is often absent because the nerve pathway to the calf muscle is damaged. This sign helps doctors confirm that there is a peripheral neuropathy affecting the lower limbs.Rare Diseases Information Center+1

7. Hyperactive knee reflexes (hyperactive patellar reflex)
   While ankle reflexes may be absent, knee reflexes can be unusually brisk in CMT2H, due to pyramidal tract involvement. This combination—no ankle reflexes plus very strong knee reflexes—is unusual and raises suspicion for this specific subtype with central pathway involvement.Rare Diseases Information Center+2Monarch Initiative+2

8. Upper limb hyperreflexia
   Some people also have increased reflexes in the arms. When the doctor taps the elbow or wrist reflex points, the response may be stronger than normal. This again reflects mild damage to the corticospinal tracts and helps confirm that CMT2H is different from more “pure” peripheral neuropathies.Rare Diseases Information Center+1

9. Distal sensory loss in feet and legs
   Many patients lose feeling in a “stocking” pattern, starting in the toes and slowly moving upward. They may have trouble feeling light touch, pain, or temperature in their feet. This increases the risk of unrecognized injuries, such as cuts or blisters, and contributes to poor balance.Rare Diseases Information Center+2Physiopedia+2

10. Numbness, tingling, or “pins and needles”
    Along with reduced sensation, people often report tingling or “pins and needles” feelings in the feet and sometimes the hands. These abnormal sensations (paresthesias) occur because damaged sensory nerves send confusing or spontaneous signals to the brain.Wikipedia+1

11. Balance problems and frequent falls
    Because of weak muscles, altered foot shape, and poor sensation, standing and walking on uneven ground can be hard. People may stagger, lose their balance in the dark, or fall more often than others. Balance problems are a major source of disability and anxiety in CMT.Charcot-Marie-Tooth Association+1

12. Difficulty running and doing sports
    Children with CMT2H often cannot keep up with peers during running games or sports. They may tire quickly, trip, or avoid physical activities. This difficulty is often the first thing parents notice and is related to early distal weakness and foot drop.Mayo Clinic+1

13. Weakness in hands and fine-motor problems (later)
    As the disease progresses, the hands can also be affected. Tasks that require fine finger control, like writing, buttoning clothes, or using small objects, become harder. This happens because the long nerves to the hands gradually develop the same axonal damage seen in the legs.NCBI+1

14. Leg stiffness or spastic feelings
    Some people with CMT2H feel stiffness or tightness in the legs, especially when walking or trying to move quickly. This can be due to pyramidal tract involvement causing increased muscle tone, combined with weakness and contractures from long-term neuropathy.Rare Diseases Information Center+2Monarch Initiative+2

15. Fatigue, aches, or cramps in legs and feet
    Walking with weak, imbalanced muscles takes more effort. Over time, this leads to fatigue, aching, and sometimes painful cramps in the feet and calves. Pain can also come from abnormal joint loading due to foot deformities. Managing fatigue and pain is an important part of care.Charcot-Marie-Tooth Association+2mcri.edu.au+2

---

Diagnostic tests

Doctors use a mix of physical examination, manual bedside tests, lab and pathological tests, electrodiagnostic studies, and imaging to diagnose CMT2H and to rule out other causes of neuropathy.

Physical examination tests

1. General neurological examination
   The doctor first takes a careful history and performs a full neurological exam. They check muscle strength, sensation, reflexes, and coordination in both arms and legs. The pattern of distal weakness, sensory loss, and mixed reflex changes suggests a hereditary neuropathy like CMT2H rather than a single nerve injury.NCBI+1

2. Gait observation and functional walking tests
   The doctor watches the person walk normally, on heels, and on toes. A high-stepping gait, foot drop, and difficulty heel-walking are important signs. These simple bedside tests give a quick picture of how the neuropathy and pyramidal involvement are affecting movement.Muscular Dystrophy Association+1

3. Inspection of feet and legs for deformities
   The examiner looks for high-arched feet, curled toes, thin calves, and ankle instability. The shape of the feet and lower legs often gives a strong clue toward long-standing CMT. These changes are not specific for CMT2H but strongly support a chronic hereditary neuropathy.Mayo Clinic+1

4. Reflex testing (ankle, knee, and upper limb reflexes)
   Using a reflex hammer, the doctor tests Achilles (ankle), patellar (knee), and arm reflexes. In CMT2H, ankle reflexes are usually absent, while knee and sometimes arm reflexes are brisk, showing both peripheral and pyramidal involvement. This unusual combination is a diagnostic clue for this subtype.Rare Diseases Information Center+1

5. Muscle tone and coordination assessment
   The doctor gently moves the limbs to feel muscle tone and asks the person to perform coordination tasks, like touching their finger to their nose. Slightly increased tone in the legs together with distal weakness and sensory loss supports the picture of CMT2H with pyramidal signs rather than a pure spinal cord disease.NCBI+1

Manual bedside tests

6. Manual muscle testing (MRC grading)
   The clinician tests specific muscle groups, such as ankle dorsiflexors and plantarflexors, by asking the person to push or pull against hand resistance. Strength is graded on a standard scale (often 0–5). Distal muscles are weaker than proximal ones, and this pattern helps separate CMT2H from primary muscle diseases.NCBI+1

7. Vibration sense with a tuning fork
   A vibrating tuning fork is placed on the ankles and toes to see how well the person feels vibration. In CMT2H, vibration sense may be reduced distally because large sensory fibers are damaged. This simple manual test gives information similar to more complex nerve studies.Physiopedia+1

8. Joint position sense testing (proprioception)
   The doctor gently moves the big toe up and down while the patient closes their eyes and asks whether it is pointing up or down. Poor performance suggests loss of proprioceptive fibers, which contributes to balance problems and falls. This test helps document sensory involvement in CMT2H.Physiopedia+1

9. Light touch and pinprick testing
   Cotton, a soft brush, or a blunt pin can be used to test light touch and pain sensation on the feet and hands. In CMT2H, the person often feels less or cannot tell the difference in the distal parts of the limbs. Mapping out sensory loss helps describe the severity and distribution of the neuropathy.Rare Diseases Information Center+2Wikipedia+2

10. Balance tests (Romberg and tandem gait)
    In the Romberg test, the patient stands with feet together and then closes their eyes; increased swaying or falling suggests loss of proprioception. Tandem gait (walking heel-to-toe in a straight line) also tests balance. People with CMT2H may perform poorly because of both sensory loss and weakness.Physiopedia+1

Laboratory and pathological tests

11. Genetic testing panels for CMT
    Modern genetic panels test many CMT-related genes at once and can sometimes confirm that a person’s neuropathy matches the CMT2H locus on chromosome 8. Even when the exact gene is still being characterized, genetic testing can rule in or rule out many other CMT subtypes and support a diagnosis of autosomal recessive CMT2.NCBI+2MalaCards+2

12. Family (segregation) testing and carrier testing
    When a variant is found, testing parents and siblings helps show that it fits an autosomal recessive pattern: both parents carry one copy, and affected children have two copies. This kind of segregation study strengthens the diagnosis and can guide genetic counseling for future pregnancies.Rare Diseases Information Center+2MedlinePlus+2

13. Routine blood tests to exclude acquired neuropathies
    Blood tests such as fasting glucose/HbA1c, vitamin B12, thyroid hormones, kidney and liver function, and tests for certain toxins or infections are done to rule out acquired causes of neuropathy. Normal results do not prove CMT2H but help exclude other treatable conditions, supporting a genetic diagnosis.NCBI+1

14. Nerve biopsy with histopathology
    In difficult cases, a small piece of a sensory nerve (often from the lower leg) may be removed and studied under the microscope. In axonal CMT, biopsy can show reduced numbers of myelinated fibers, signs of axonal degeneration, and attempts at regeneration. Because it is invasive, this test is now less common but can still be useful in selected patients.Rare Diseases Information Center+2NCBI+2

15. Cerebrospinal fluid (CSF) analysis (selected cases)
    A lumbar puncture to analyze CSF is not routine for CMT2H but may be used to rule out inflammatory or immune-mediated neuropathies if the clinical picture is unclear. Normal or only slightly changed CSF supports a hereditary neuropathy rather than an acquired inflammatory one.NCBI+1

Electrodiagnostic tests

16. Nerve conduction studies (NCS)
    NCS measure how fast and how strongly electrical signals travel along nerves. In CMT2H, results usually show reduced amplitudes of motor and sensory responses (showing axonal loss) with relatively preserved or only mildly slowed conduction velocities. This pattern supports an axonal sensorimotor polyneuropathy rather than a demyelinating one.NCBI+2Physiopedia+2

17. Electromyography (EMG)
    EMG uses a thin needle to record activity from muscles. In CMT2H, EMG often shows signs of chronic denervation and re-innervation, such as large motor units and reduced recruitment. These findings confirm that the problem lies in the nerves supplying the muscles, not in the muscles themselves.NCBI+1

18. Evoked potential studies (for pyramidal involvement)
    Somatosensory or motor evoked potentials can be used when doctors suspect central (pyramidal) involvement. These tests measure how signals travel through the spinal cord and brain. Abnormalities can support the idea that corticospinal tracts are involved in addition to peripheral nerves in CMT2H.Springer Link+1

Imaging tests

19. MRI of brain and spinal cord
    MRI imaging is mainly used to exclude other causes of pyramidal signs, such as structural spinal cord lesions or multiple sclerosis. Occasionally, subtle changes in corticospinal tracts may be seen. A normal MRI with typical peripheral findings supports the diagnosis of CMT2H rather than another central nervous system disease.NCBI+1

20. X-rays or other imaging of feet and ankles
    Plain X-rays of the feet and ankles help document pes cavus, hammertoes, and other bone changes. Orthopedic surgeons and physiatrists use these images to plan braces or surgery if needed. While these images do not diagnose CMT2H directly, they show the structural effects of long-term neuropathy on the skeleton.Muscular Dystrophy Association+1

Non-pharmacological treatments

These supportive therapies are the core of CMT2H care and should start early and continue regularly. Physiopedia+2PMC+2

1. Physiotherapy strength training
A physiotherapist designs gentle strengthening exercises for the lower legs, hips, and core muscles. The purpose is to slow muscle wasting, improve walking, and delay contractures. The main mechanism is repeated, low-to-moderate resistance exercise that keeps remaining motor units active and improves coordination without over-fatiguing weak muscles.

2. Stretching to prevent contractures
Daily stretching of calves, hamstrings, hip flexors, and toe flexors keeps muscles long and joints moving. The purpose is to prevent fixed deformities such as tight Achilles tendons and claw toes. Stretching works by slowly lengthening muscle and connective tissue, reducing stiffness and helping maintain normal joint position. Physiopedia+1

3. Balance and gait training
Because CMT2H affects sensation and strength, balance and walking can become unsafe. Balance training uses simple tasks like standing on different surfaces, stepping exercises, and gait drills to train the brain and sensory system to use vision and remaining sensation better. This reduces falls and builds confidence. PMC

4. Aerobic conditioning (low-impact exercise)
Safe activities such as swimming, cycling, or walking with support keep the heart and lungs strong without overloading weak feet and ankles. The purpose is to reduce fatigue and support healthy weight. The mechanism is improved blood flow, better mitochondrial function, and overall fitness, which helps nerves and muscles use oxygen more efficiently. PMC+1

5. Occupational therapy (OT)
An occupational therapist helps with hand weakness, handwriting, using phones or keyboards, dressing, and cooking. The goal is to make daily activities easier and safer by teaching joint-protection techniques and adaptive strategies. OT works by breaking big tasks into small steps and using special tools, such as built-up pens, button hooks, and adapted cutlery. PMC+1

6. Ankle-foot orthoses (AFOs) and braces
AFOs are light plastic or carbon braces worn inside or over shoes to control foot drop and ankle wobbling. Their purpose is to improve foot clearance, reduce tripping, and correct high-arched (cavus) or turned-in (varus) feet as much as possible. They work by holding the ankle in a stable, slightly flexed position so muscles do not need to work as hard with each step. Charcot-Marie-Tooth Association+2The Foundation for Peripheral Neuropathy+2

7. Custom shoes and insoles
Soft, wide shoes with support and custom insoles spread pressure under the foot and protect bony areas from calluses and ulcers. For cavus feet, extra cushioning under the ball of the foot and heel cups help. The mechanism is simple pressure redistribution, which lowers pain and skin breakdown risk. Wikipedia+1

8. Assistive walking devices (cane, crutches, walker)
When balance is poor or falls are frequent, a cane or walker can make walking safer. The purpose is not to “give up walking” but to extend safe mobility. These devices shift part of the body weight through the arms, widen the base of support, and reduce the force on weak ankles and feet. PMC+1

9. Hand therapy and fine-motor training
Special hand exercises, putty, grip tools, and finger coordination tasks can help compensate for hand weakness. The goal is to preserve writing, using zippers and buttons, and phone use. Mechanism: repetitive practice strengthens remaining motor units and helps the brain reorganize movement patterns for better control. PMC

10. Pain self-management (heat, cold, TENS)
For musculoskeletal pain, local heat pads, gentle massage, and supervised TENS (transcutaneous electrical nerve stimulation) can be used. The purpose is to reduce pain signals and muscle spasm without extra medicines. Heat and TENS work by blocking pain signals at the spinal cord level and relaxing tight muscles. PMC+1

11. Fatigue and energy-conservation training
Therapists teach planning and pacing: resting before becoming exhausted, sitting to do tasks, and spreading heavy work across the day. The purpose is to reduce extreme tiredness and maintain independence. The mechanism is mainly behavioral—using energy more efficiently to avoid repeated overloading of weak muscles. Dove Medical Press+1

12. Home fall-prevention changes
Simple changes such as removing loose rugs, adding grab bars and nightlights, and keeping floors clear reduce fall risk. The goal is to protect bones and joints from fractures that can severely worsen disability. The mechanism is environmental control—removing hazards so impaired balance is less dangerous. Mayo Clinic

13. Podiatry and foot-care program
Regular visits to a podiatrist for nail care, callus trimming, and inspection of pressure areas help prevent ulcers and infections, especially if sensation is reduced. This works by detecting small problems early and reducing mechanical stress on vulnerable skin. upload.orthobullets.com+1

14. Weight management and healthy general exercise
Maintaining a healthy body weight reduces the load on weak ankles and feet and lowers pain. Simple whole-body movement, within limits, improves blood sugar control and reduces cardiovascular risk, which also benefits nerve health. Mayo Clinic+1

15. Psychological counseling and coping support
Living with a lifelong progressive disease can cause stress, sadness, or anxiety. Counseling, cognitive-behavioral therapy, or support groups help people understand the disease, cope with uncertainty, and keep motivation for exercises and self-care. This improves quality of life and lowers the perception of pain and fatigue. Dove Medical Press+1

16. School and vocational rehabilitation
For teenagers and adults, counseling about school choices and future jobs is important. The purpose is to find study and work paths that respect physical limits but still match interests and strengths. Vocational rehab adapts workplaces and suggests tools to keep employment possible for longer. Dove Medical Press

17. Sleep hygiene and positioning aids
Good sleep habits (regular schedule, quiet dark room, avoiding screens in bed) plus pillows or splints to support ankles and wrists at night reduce pain and cramps. Better sleep lets nerves and muscles recover and lowers daytime fatigue. PMC+1

18. Respiratory and speech therapy (if needed)
In severe or pyramidal-involved cases, breathing muscles or swallowing can be affected. Respiratory therapy, breathing exercises, and sometimes non-invasive ventilation at night may be used. Speech and swallowing therapists help with safe eating and voice control. Rare Diseases Information Center+1

19. Genetic counseling for family planning
Because CMT2H is inherited, genetic counseling explains the pattern of inheritance, risks to children, and available genetic testing. The mechanism is education and informed decision-making, not disease modification. MalaCards+1

20. Patient organizations and peer support
Charcot-Marie-Tooth associations provide information, webinars, exercise videos, and emotional support. Peer support reduces isolation and offers practical tips for daily living from people with the same condition. Charcot-Marie-Tooth Association+1

---

Drug treatments

There is no FDA-approved drug that specifically cures or slows CMT2H itself. Medicines are used to treat neuropathic pain, cramps, mood, and sleep problems. Many of them are approved for other neuropathic conditions (like diabetic neuropathy) and are used “off-label” in hereditary neuropathies. Always ask your neurologist before starting, stopping, or changing any medicine. Dove Medical Press+1

Below are important examples (not a full list). Doses are typical adult ranges from labels; for children and teenagers, dosing is very different and must be set by a specialist.

1. Gabapentin (Neurontin)
Class: Anticonvulsant/neuropathic pain agent.
Typical adult dose: Titrated from 300 mg/day up to 1800–3600 mg/day in divided doses for neuropathic pain, adjusted for kidney function. FDA Access Data+1
Purpose: Reduce shooting, burning neuropathic pain and improve sleep.
Mechanism: Binds to the α2δ subunit of voltage-gated calcium channels and reduces release of excitatory neurotransmitters, lowering pain signaling. FDA Access Data+1
Common side effects: Sleepiness, dizziness, weight gain, leg swelling, and sometimes mood changes.

2. Pregabalin (Lyrica)
Class: Anticonvulsant/neuropathic pain agent.
Typical adult dose: Often 150–300 mg/day in divided doses for neuropathic pain, with a maximum of around 600 mg/day depending on indication and kidney function. FDA Access Data+2FDA Access Data+2
Purpose: Treat moderate to severe neuropathic pain and improve sleep quality.
Mechanism: Similar to gabapentin; binding to the α2δ subunit reduces calcium-dependent release of pain-related neurotransmitters in the spinal cord. NCBI+1
Side effects: Dizziness, drowsiness, swelling in legs, blurred vision, and weight gain.

3. Duloxetine (Cymbalta)
Class: Serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant.
Typical adult dose: 60 mg once daily for diabetic peripheral neuropathic pain; higher doses rarely needed and not usually more effective. FDA Access Data+1
Purpose: Reduce neuropathic pain and also help with anxiety or depression that can accompany chronic illness.
Mechanism: Increases serotonin and norepinephrine in pain-control pathways of the brain and spinal cord, lowering pain perception. NCBI+1
Side effects: Nausea, dry mouth, sweating, raised blood pressure, sleep disturbance, and rarely liver issues.

4. Amitriptyline
Class: Tricyclic antidepressant.
Typical adult dose for neuropathic pain: Often starts at 10–25 mg at night and slowly increased; lower doses than for depression. Medicines.org.uk+1
Purpose: Night-time pain control and better sleep.
Mechanism: Blocks reuptake of serotonin and norepinephrine and also has sodium-channel blocking effects, which together reduce chronic pain signaling. PMC+2ScienceDirect+2
Side effects: Dry mouth, constipation, drowsiness, weight gain, and in some people heart rhythm problems—so ECG monitoring may be needed.

5. Topical lidocaine 5% patch (Lidoderm)
Class: Local anesthetic patch.
Typical adult use: Applied to painful area up to 12 hours on, 12 hours off each day for localized neuropathic pain. FDA Access Data+2NHS England+2
Purpose: Treat well-localized burning pain in the feet without large whole-body side effects.
Mechanism: Blocks voltage-gated sodium channels in the skin’s nerve endings, stopping abnormal firing from damaged small nerve fibers. PubMed
Side effects: Local skin irritation or redness; systemic side effects are rare when used correctly.

6. Capsaicin 8% patch (Qutenza)
Class: High-concentration topical analgesic.
Typical adult use: Single patch session applied in clinic for 30–60 minutes, may give pain relief for weeks in localized neuropathic pain. FDA Access Data+2European Medicines Agency (EMA)+2
Purpose: For severe, localized neuropathic pain not controlled by oral drugs.
Mechanism: Strongly activates and then desensitizes TRPV1 pain receptors and temporarily reduces epidermal nerve fiber density, lowering pain input from that skin area. PubMed+1
Side effects: Burning, redness, and pain at the application site during and shortly after treatment.

7. Tramadol (Ultram, Ultram ER)
Class: Weak opioid and SNRI-like analgesic.
Typical adult dose: Varies; used for moderate–severe pain when other treatments fail, with strict limits because of dependence risk. FDA Access Data+2FDA Access Data+2
Purpose: Short-term control of severe musculoskeletal or neuropathic pain.
Mechanism: Binds to μ-opioid receptors and inhibits reuptake of serotonin and norepinephrine, reducing pain transmission. NCBI
Side effects: Nausea, dizziness, constipation, and risk of addiction, breathing problems, and seizures—so it must be used very carefully and often avoided in young people.

8. NSAIDs (e.g., ibuprofen, naproxen)
Class: Non-steroidal anti-inflammatory drugs.
Purpose: Treat joint and muscle pain linked to abnormal walking, but they do not treat neuropathic pain itself.
Mechanism: Inhibit cyclo-oxygenase enzymes and reduce prostaglandin production, lowering inflammation and nociceptive pain. Dove Medical Press+1
Side effects: Stomach irritation, kidney strain, and increased bleeding risk with long-term or high-dose use.

9. Baclofen
Class: Antispasticity muscle relaxant.
Typical adult dose: Titrated slowly (for example starting 5 mg 3 times daily) according to response; exact dose must be individualized. NIHR Innovation Observatory+1
Purpose: Reduce muscle stiffness and cramps in people with pyramidal signs or spasticity.
Mechanism: GABA-B receptor agonist that decreases excitatory neurotransmission in spinal motor circuits, reducing reflex over-activity. NIHR Innovation Observatory+1
Side effects: Drowsiness, weakness, dizziness, and risk of withdrawal reactions if stopped suddenly.

10. Tizanidine
Class: α2-adrenergic agonist muscle relaxant.
Purpose: Alternative to baclofen for muscle spasm and stiffness.
Mechanism: Reduces excitatory input to spinal motor neurons, lowering muscle tone. Dove Medical Press
Side effects: Sleepiness, dry mouth, low blood pressure, and liver enzyme elevations.

11. SSRIs or SNRIs for mood (e.g., sertraline, venlafaxine)
Class: Antidepressants.
Purpose: Treat depression or anxiety related to chronic disability and pain. Improved mood can also reduce pain perception.
Mechanism: Increase serotonin and/or norepinephrine in brain circuits controlling mood and pain modulation. NCBI+1

12. Sleep aids when needed (low-dose melatonin or prescribed hypnotics)
Class: Variable, depending on agent.
Purpose: Improve sleep when pain and cramps disturb rest; good sleep helps daytime function and pain tolerance.
Mechanism: Melatonin resets circadian rhythm; other hypnotics act on GABA or other receptors to promote sleep. Must be used very cautiously and only under medical supervision, especially in teenagers. Dove Medical Press+1

(Other medicines may be used case-by-case; your neurologist will consider age, other illnesses, and interactions.)

---

Dietary molecular supplements

Supplements may support general nerve and muscle health, but they do not replace physiotherapy or prescribed medicines. Evidence for CMT2H is limited, so use them only with medical advice. Dove Medical Press+1

1. Alpha-lipoic acid
An antioxidant used in diabetic neuropathy trials, usually in doses around 300–600 mg/day in adults. It helps recycle other antioxidants like glutathione and vitamin C, which may reduce oxidative stress in nerves. Some studies show modest improvement in neuropathic symptoms, but long-term benefit in hereditary neuropathies is not proven. ej-med.org

2. Acetyl-L-carnitine
Often used at 500–1000 mg two or three times daily in adults. Carnitine helps transport fatty acids into mitochondria for energy production, which may support energy-hungry nerve cells. Small studies in neuropathies suggest possible benefit in nerve regeneration and pain reduction. ej-med.org+1

3. Coenzyme Q10 (ubiquinone)
Typical adult supplemental doses are 100–300 mg/day. CoQ10 is part of the mitochondrial electron transport chain and acts as an antioxidant. The idea is that better mitochondrial function might support axonal survival. Evidence in CMT is limited, but it is sometimes tried in mitochondrial and neuromuscular disorders. ej-med.org+1

4. Omega-3 fatty acids (EPA/DHA)
Commonly used at 1000–2000 mg total EPA/DHA per day in adults. Omega-3s help build cell membranes and may reduce inflammation. They might support nerve membrane health and cardiovascular health, which indirectly benefits nerves. ej-med.org

5. B-complex vitamins (especially B1, B6, B12)
Deficiency of B vitamins can worsen neuropathy, so correcting low levels is important. Doses depend on blood levels and must avoid B6 overdose, which can itself cause neuropathy. These vitamins are co-factors in energy production and myelin synthesis. Dove Medical Press+1

6. Vitamin D
Low vitamin D is common and linked to muscle weakness and bone problems. Supplement doses vary based on blood tests. Vitamin D supports bone strength, muscle function, and immune regulation, all important in people with long-term mobility limits. Dove Medical Press

7. Magnesium
Sometimes used in modest doses to help with muscle cramps and sleep. Magnesium plays roles in nerve conduction and muscle relaxation. Too much can cause diarrhea and, in kidney disease, dangerous levels, so monitoring is needed. Dove Medical Press

8. Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant actions in experimental models. It may modulate signaling pathways and reduce oxidative stress. Human data in hereditary neuropathy are very limited, so it should be considered only as a supportive anti-inflammatory food component, not a treatment. ej-med.org

9. Resveratrol
A plant polyphenol with antioxidant and possible mitochondrial-support effects. Laboratory studies suggest it may protect nerves from oxidative damage, but clinical evidence for peripheral neuropathy is still weak. ej-med.org+1

10. N-acetylcysteine (NAC)
NAC is a precursor of glutathione, the main intracellular antioxidant. It has been studied in various neurological conditions. The idea is to boost the cell’s ability to handle oxidative stress. Any use should be supervised because high doses can affect the gut and, rarely, other organs. ej-med.org+1

---

Regenerative, immunity-booster, and stem-cell–related approaches

Right now, there are no approved regenerative or stem-cell drugs for CMT2H. However, important research directions exist. MDPI+4PubMed+4Agence nationale de la recherche+4

1. Gene therapy targeting axonal CMT (like CMT2A)
Researchers are testing gene therapy for MFN2-related CMT2A by silencing the mutant gene and replacing it with a healthy copy using viral vectors. The aim is to correct the root genetic cause and restore healthy mitochondrial function in motor neurons. Early laboratory and animal results are promising but still experimental. Charcot-Marie-Tooth Disease+5PubMed+5BSGCT+5

2. CRISPR-based genome editing programs
Some teams are using CRISPR to specifically switch off the mutant MFN2 allele in axonal CMT2A, which is closely related to other axonal types. The purpose is to prevent the toxic mutant protein from harming nerves. This approach is still in preclinical or very early clinical stages, so there is no standard dosing or routine clinical use. Charcot-Marie-Tooth Association+1

3. Neurotrophic and “disease-modifying” combinations (e.g., PXT3003 in CMT1A)
PXT3003 is a low-dose combination of baclofen, naltrexone, and sorbitol being tested as a disease-modifying therapy in CMT1A. It aims to reduce over-expression of PMP22, improve myelination, and preserve axons. Although this is for CMT1A, it shows the concept of combination therapies that target underlying biology rather than only symptoms. Clinical Trials Register+4PubMed+4NIHR Innovation Observatory+4

4. Mesenchymal stem cell (MSC) therapies for peripheral neuropathy
Clinical and experimental studies in diabetic and other neuropathies are testing MSCs from bone marrow, adipose tissue, or umbilical cord. These cells release growth factors and exosomes that may reduce inflammation, support blood vessels, and stimulate axon regeneration. Results are early but show some improvement in nerve conduction and symptoms in other neuropathies. MDPI+5ClinicalTrials.gov+5ScienceDirect+5

5. Induced pluripotent stem cell (iPSC) models
Some centers create iPSCs from patients’ skin cells and turn them into nerve cells in the lab. This is mainly a research tool to study disease mechanisms and test new drugs in “personalized” nerve cells. Although not a treatment itself, it is a key step toward future regenerative therapies. Mayo Clinic+1

6. Experimental neuroprotective and anti-oxidant drug strategies
Various small molecules are being studied to improve mitochondrial function, reduce oxidative stress, or enhance axonal transport in hereditary neuropathies. These include antioxidant cocktails and metabolic modulators. For now, these approaches remain in trials or preclinical models, so there is no standard regimen for CMT2H. ScienceDirect+2ej-med.org+2

---

Surgical treatments

Surgery does not treat the nerve disease itself. It corrects bone and soft-tissue deformities, mainly in the feet, to improve standing, walking, and shoe comfort. Decisions depend on deformity type, flexibility, and age. MDPI+4PubMed+4upload.orthobullets.com+4

1. Plantar fasciotomy
What it is: Cutting or lengthening the tight plantar fascia under the foot.
Why it is done: In cavus foot, the tight fascia pulls the forefoot downward, increasing arch height and pain. Releasing it allows the arch to relax and makes later bone corrections easier.

2. Dorsiflexion osteotomy of the first metatarsal
What it is: A controlled bone cut in the first metatarsal to rotate it upward.
Why it is done: In CMT cavus feet, the first metatarsal often points downward, making the arch very high and shifting weight to the forefoot. Realigning it lowers the arch, spreads pressure more evenly, and improves gait. PubMed+2upload.orthobullets.com+2

3. Tendon transfers (e.g., Jones procedure, posterior tibial tendon transfer)
What it is: Moving a relatively strong tendon (such as extensor hallucis longus or posterior tibial tendon) to a new insertion to balance muscle forces around the foot and ankle.
Why it is done: In CMT, muscle imbalance (some weak, some strong) drives deformity. Tendon transfers aim to “rebalance” pulls, reduce foot drop, and improve ankle stability. ScienceDirect+3PMC+3Orthobullets+3

4. Calcaneal osteotomy (heel bone realignment)
What it is: Cutting and shifting the heel bone to correct hindfoot varus (inward tilt).
Why it is done: A tilted heel worsens instability and overloads the outer foot. Realignment places the heel under the leg, improving balance and pressure distribution. www.elsevier.com+2foot.theclinics.com+2

5. Joint fusion (arthrodesis) in severe, rigid deformity
What it is: Surgically removing cartilage and fusing joints, often in the midfoot or hindfoot, to create a stable, plantigrade foot.
Why it is done: When deformity is rigid and painful and tendon/bone procedures cannot correct it, fusion provides a stable platform for standing and walking, even though some motion is sacrificed. upload.orthobullets.com+2foot.theclinics.com+2

---

Prevention and lifestyle protection

Because CMT2H is genetic, you cannot prevent the disease itself, but you can reduce complications and disability:

1. Avoid neurotoxic medicines such as vincristine and some other chemotherapy drugs known to worsen neuropathy; always remind doctors you have hereditary neuropathy. Dove Medical Press+1

2. Protect feet with good shoes, daily inspection, and podiatry visits to prevent ulcers and infections. upload.orthobullets.com+1

3. Use braces and walking aids early if recommended, rather than waiting for many falls.

4. Maintain healthy body weight to lower stress on weak ankles and knees. Mayo Clinic+1

5. Stay physically active within safe limits to keep muscles and heart as strong as possible.

6. Do regular stretching and physiotherapy to delay contractures and joint deformity. Physiopedia+1

7. Keep bones strong with adequate vitamin D, calcium in the diet, and weight-bearing exercise as tolerated. Mayo Clinic

8. Avoid smoking and limit alcohol, because both can damage peripheral nerves further. Mayo Clinic+1

9. Get vaccinated (for example flu and pneumonia), because severe infections can temporarily worsen weakness and fatigue. Mayo Clinic

10. Use genetic counseling for family planning so relatives understand their risk and testing options. MalaCards+1

---

When to see doctors – and when it is urgent

You should have regular scheduled follow-up with a neurologist and rehabilitation team, usually at least once a year or more often if symptoms change. Dove Medical Press+1

Seek non-emergency medical review soon if you notice:

• New or clearly worse weakness in feet, legs, hands, or arms.

• More frequent trips, falls, or ankle sprains.

• New or rapidly increasing burning or shooting pain.

• Changes in foot shape, pressure areas, blisters, or calluses that do not heal.

• Mood changes, low mood, or loss of interest in usual activities.

Seek urgent or emergency care if:

• You suddenly cannot walk or stand when you could before.

• You have rapid loss of hand function, severe back pain with weakness, or sudden change in bladder or bowel control (to rule out other emergencies such as spinal problems).

• You have severe shortness of breath, chest discomfort, or trouble swallowing.

In all cases, because you are a teenager, decisions should be made together with your parents or guardians and your specialist team.

---

What to eat and what to avoid

Food cannot cure CMT2H, but a smart diet supports your muscles, bones, and nerves and helps you stay at a healthy weight.

What to eat (5 points)

1. Plenty of colorful vegetables and fruits for vitamins, minerals, and antioxidants that support general nerve and muscle health. ej-med.org+1

2. Lean proteins such as fish, eggs, beans, tofu, and poultry to provide amino acids for muscle repair and enzymes.

3. Healthy fats, especially omega-3-rich foods (fatty fish, walnuts, flaxseed) that may support cell membranes and reduce inflammation. ej-med.org

4. Whole grains (brown rice, oats, whole-grain bread) for stable energy, fiber, and B-vitamins that help nerve function.

5. Calcium- and vitamin-D–rich foods (dairy, fortified plant milks, small bony fish, eggs) to support bone strength in less active limbs. Mayo Clinic

What to avoid or limit (5 points)

6. Excessive sugary drinks and sweets, which can promote weight gain and blood sugar problems that stress nerves.

7. Highly processed foods and fast food high in salt, trans fats, and additives, which add calories with little nutrition.

8. Too much alcohol, because it can directly damage nerves and interact with many medicines. Mayo Clinic+1

9. Crash diets or very low-calorie plans, which can cause muscle loss and micronutrient deficiencies that worsen weakness.

10. Mega-doses of supplements without testing, especially vitamin B6 or fat-soluble vitamins, because very high levels can be harmful to nerves and organs. Always check with your doctor. Dove Medical Press+1

---

Frequently asked questions (FAQs)

1. Is CMT2H the same as other Charcot-Marie-Tooth types?
No. CMT2H is an axonal type with specific genetic causes and often pyramidal signs. All CMT types share progressive peripheral neuropathy, but the exact gene, pattern of nerve damage, and severity can differ. MalaCards+2Monarch Initiative+2

2. Can CMT2H be cured right now?
At present there is no cure and no medicine that fully stops progression. Management focuses on symptoms, function, and complication prevention. Research in gene therapy and stem-cell approaches is active and offers hope for the future, but it is not standard care yet. PubMed+2Passage Bio+2

3. What is the long-term outlook (prognosis)?
CMT2H usually progresses slowly over years. Many people keep the ability to walk, especially with braces and physiotherapy, though they may need aids later. Life expectancy is usually near normal when serious complications (falls, injuries, infections) are prevented. Mayo Clinic+1

4. Does exercise make CMT2H worse?
Heavy, exhausting exercise that causes repeated injuries can be harmful. But properly guided, low-impact exercise helps maintain strength, flexibility, and cardiovascular fitness and is recommended. A physiotherapist can design a safe program. PMC+2Physiopedia+2

5. Are pain medicines always necessary?
Not always. Some people have little pain and mainly need braces and physiotherapy. When neuropathic pain is present, drugs like gabapentin, pregabalin, or duloxetine can be added carefully. Medicines should be combined with non-drug strategies like heat, stretching, and counseling. NCBI+3Dove Medical Press+3FDA Access Data+3

6. Do I have to take tramadol or other opioids?
Most people with CMT can manage pain without opioids. Tramadol and stronger opioids carry addiction and breathing risks, so they are reserved for short-term severe pain when other options fail and must be closely supervised, especially in younger patients. FDA Access Data+2NCBI+2

7. Can diet alone fix my nerve damage?
No diet can reverse the genetic nerve damage in CMT2H. However, good nutrition, healthy weight, and correcting deficiencies (like vitamin D or B-vitamins) support overall health and may help your body cope better. Mayo Clinic+1

8. Are stem-cell treatments on the internet safe?
Many commercial “stem-cell clinics” advertise cures but are not supported by strong evidence and may be unsafe. Real stem-cell therapy for neuropathy is still in clinical trials with strict rules. Always discuss any such offer with your neurologist and avoid unregulated treatments. MDPI+3ClinicalTrials.gov+3ScienceDirect+3

9. Should my brothers or sisters be tested?
Because CMT2H is genetic, siblings may carry the same gene changes. Genetic counseling can explain the pros and cons of testing, including emotional effects and future planning. Testing decisions are personal and should be made with family and specialists. MalaCards+1

10. Will I need surgery for my feet?
Not everyone needs surgery. Many people manage with AFOs and good shoes. Surgery is usually considered when deformities are painful, rigid, or causing frequent falls despite optimal conservative care. An orthopedic surgeon experienced in CMT will guide timing and type of procedure. PubMed+2upload.orthobullets.com+2

11. Can CMT2H affect my breathing or swallowing?
Most people have mainly leg and sometimes hand problems, but in more severe or mixed cases, respiratory muscles or swallowing may be affected. If you have shortness of breath, morning headaches, or choking episodes, tell your doctor; you may need respiratory or swallowing evaluation. Rare Diseases Information Center+1

12. Is it safe to become pregnant if I have CMT2H?
Many people with CMT have successful pregnancies. However, pregnancy can increase strain on feet and back and may temporarily worsen symptoms. Genetic counseling before pregnancy can discuss the chance of passing the condition on to children and available options. Mayo Clinic+2MalaCards+2

13. Will school or work be impossible?
Most people with CMT can go to school, university, and work with adaptations such as accessible classrooms, elevators, ergonomic desks, rest breaks, and flexible schedules. Early planning with teachers and employers helps keep you active and independent. Dove Medical Press+1

14. Are there special shoes I must buy?
No single brand is best, but shoes should be wide, cushioned, and supportive, with space for orthoses. Rocker-bottom soles and extra-depth shoes often help. A podiatrist or orthotist can recommend styles that match your foot shape and braces. upload.orthobullets.com+1

15. Where can my family learn more and meet others with CMT?
National and international CMT organizations, neuromuscular clinics, and rare-disease networks provide reliable information, online communities, and support groups. They also share news about ongoing clinical trials, including gene- and stem-cell–based research. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Association+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.